Navigation Links
Samaritan Partners 'Forgetful' Rat Model to Taconic to Commercialize
Date:10/1/2008

The Samaritan Alzheimer's Rat Model

- Mimics Human Alzheimer's

- Speeds 'Race for Time' to Find Cure

- Saves Valuable Research Money

LAS VEGAS, Oct. 1 /PRNewswire-FirstCall/ -- Samaritan Pharmaceuticals (OTC Bulletin Board: SPHC) (http://www.samaritanpharma.com) and Taconic Farms, Hudson, New York, are pleased to announce they have inked a worldwide partnering agreement to commercialize "The Samaritan Alzheimer's Rat Model." The "forgetful" rat model is a research tool used by scientists to study the effectiveness of their new drugs to treat Alzheimer's disease. The unique benefits of the rat model lie in its ability,

-- To mimic many features of human Alzheimer's including memory loss,

-- Speed a scientist's "race for time" in finding a cure for the

mind-robbing disease

-- Save scientists valuable research money.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081001/LAW054)

The rat model is now available exclusively through Taconic. Samaritan will receive royalties on net sales. Financial terms were not disclosed.

"Taconic is extremely pleased to offer researchers a new and potentially invaluable weapon in the war on neurodegenerative disease," said Todd Little, President of Taconic. "The rapid time to disease state of the Samaritan Alzheimer's Rat Model will enable investigators to conduct Alzheimer's drug target screening on a much faster timeline than ever before."

The rat model is published in Pharmacology, 2006;76:19-33

"Taconic provides us with an experienced partner to monetize this unique animal model to 'rat out' Alzheimer's. The rat model is groundbreaking, in that it offers significant advantages over other options previously available for the study of Alzheimer's. We anticipate Taconic achieving and surpassing projected market penetrations in international markets," said Dr. Greeson, CEO, Samaritan Pharmaceuticals.

Samaritan's Phase I, Alzheimer's drug Caprospinol (SP-233), utilized "The Samaritan Alzheimer's Rat Model." and the Morris Water Maze, in an IND enabling, proof of concept study. Treated rats demonstrated Caprospinol's efficacy by,
-- clearing beta-amyloid plaque formation

-- restoring the memory of tested rats

-- protecting mitochondria function

-- protecting cell viability

-- decreasing cell death

Samaritan Pharmaceuticals: "Transforming Today's Science Into Tomorrow's Cures."

Samaritan Pharmaceuticals is a biopharmaceutical company committed to bringing innovative life-saving drugs to suffering patients. Samaritan website: http://www.samaritanpharma.com. Please register for upcoming conference calls, news, and events.

Taconic Farms, Inc.

Taconic was founded in 1952 as a family-owned business in New York's Hudson River Valley. Since then, the company has become one of the largest laboratory rodent providers in the world with a reputation for consistently producing high quality, well-defined rats and mice. Taconic has six breeding facilities and three service laboratories in the USA and Europe, a staff of over 900, and a commitment to technological innovation. Taconic website, http://www.taconic.com

Disclaimer

The company disclaims any information created by an outside party and endorses only information communicated by its press releases, filings, and website. This news release contains forward-looking statements that reflect management's current beliefs about the potential for its drug candidates, science, and technology. For additional information about the factors that affect the company's business, please read the company's latest Form 10-K filed April 14, 2008. The company undertakes no duty to update forward-looking statements.

Samaritan Pharma Contact: Barrie Fuller 702-735-7001 barriefuller@samaritanpharma.com


'/>"/>
SOURCE Samaritan Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
2. Riverside Partners Sells MicroCal to GE Healthcare
3. onTargetjobs and ClearedConnections Announce Online Recruitment Partnership
4. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
5. Satyam Partners with Oracle to Provide Clinical Development Applications
6. alli(TM) Partners with Breast Cancer Network of Strength(TM) to Support Women Challenged by Breast Cancer, Weight Loss or Both
7. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
8. Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options
9. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
10. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
11. NIST and partners identify tiny gold clusters as top-notch catalysts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... ... 2017 , ... EIT Digital has launched work to develop a ... studies are about to get under way for the framework, which is designed to ... concept is expected to be transferred eventually to other industries that also require efficient ...
(Date:2/16/2017)...  ArmaGen, Inc., a privately held biotechnology company ... neurological disorders, today reported preliminary evidence of cognitive ... investigational therapy for the treatment of Hurler and ... or MPS I). The initial results from an ... at the 13 th annual WORLD Symposium ...
(Date:2/16/2017)... , Feb. 16, 2017 UCHealth ( ... utilize LungDirect for pulmonary nodule patient management. In addition ... or a spot on the lung, UCHealth looks to ... manual data entry. Stephanie Brown, RN ... my nodule patients with an Excel spreadsheet, which was ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
Breaking Biology Technology:
(Date:2/7/2017)... Minn. , Feb. 7, 2017   MedNet ... supports the entire spectrum of clinical research, is pleased ... iMedNet , its innovative, highly flexible and award ... iMedNet customers. iMedNet is a proven ... provides Electronic Data Capture (EDC), but also delivers an ...
(Date:2/3/2017)... Feb. 3, 2017 A new independent identity ... Partners, LLP (IdSP) . Designed to fill a critical ... identity market, founding partners Mark Crego and ... years just in identity expertise that span federal governments, ... leadership. The Crego-Kephart combined expertise has a common theme ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
Breaking Biology News(10 mins):